Two Regions of the Human Platelet F11-Receptor (F11R) Are Critical for Platelet Aggregation, Potentiation and Adhesion

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Thrombosis and Haemostasis

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1055/s-0037-1613070PMID 12008956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Characterization and chromosomal localization of JAM-1, a platelet receptor for a stimulatory monoclonal antibody.

  2001influential reference
• X‐ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif

  2001influential reference
• Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation.

  2000influential reference
• Human junction adhesion molecule regulates tight junction resealing in epithelia.

  2000influential reference
• Platelet Agonist F11 Receptor Is a Member of the Immunoglobulin Superfamily and Identical with Junctional Adhesion Molecule (JAM): Regulation of Expression in Human Endothelial Cells and Macrophages

  2000influential reference
• NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells.

  1999cited by this paper
• Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells.

  1999cited by this paper
• Identification and characterisation of human Junctional Adhesion Molecule (JAM).

  1999influential reference
• Combined Treatment of TNF-α and IFN-γ Causes Redistribution of Junctional Adhesion Molecule(JAM) in Human Endotherial Cells.

  1999influential reference
• Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration

  1998influential reference
• Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor.

  1995cited by this paper
• Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets.

  1995influential reference
• Activation of human platelets by a stimulatory monoclonal antibody.

  1990influential reference
• Spectrophotometric quantitation of anchorage-dependent cell numbers using the bicinchoninic acid protein assay reagent.

  1990influential reference
• Identification of a unique type of thrombopathy of human platelets: defect in the exposure of active fibrinogen receptors in a patient with Friedreich's ataxia.

  1988influential reference

• Identification and Validation of JAM-A as a Novel Prognostic and Immune Factor in Human Tumors

  2024cites this paper
• SLC37A4, gene responsible for glycogen storage disease type 1b, regulates gingival epithelial barrier function via JAM1 expression

  2024cites this paper
• Ocular immune privilege and retinal pigment epithelial cells.

  2023cites this paper
• Junctional adhesion molecule-A (JAM-A) in gynecological cancers: Current state of knowledge

  2023cites this paper
• Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein

  2023cites this paper
• Effect of F11 Receptor/Junctional Adhesion Molecule-A derived Peptide on Neointimal Hyperplasia in a Murine Intimal Hyperplasia Model.

  2023cites this paper
• Junctional Adhesion Molecules: Potential Proteins in Atherosclerosis

  2022cites this paper
• Homophilic Interaction Between Transmembrane-JAM-A and Soluble JAM-A Regulates Thrombo-Inflammation

  2022cites this paper
• Relationship between the Soluble F11 Receptor and Annexin A5 in African Americans Patients with Type-2 Diabetes Mellitus

  2022cites this paper
• The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression

  2021cites this paper
• A peptide antagonist of F11R/JAM-A reduces plaque formation and prolongs survival in an animal model of atherosclerosis.

  2019cites this paper
• Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment

  2019cites this paper
• Junctional adhesion molecule-A: functional diversity through molecular promiscuity

  2018cites this paper
• Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings

  2018cites this paper
• Epitope characterization of anti-JAM-A antibodies using orthogonal mass spectrometry and surface plasmon resonance approaches

  2017cites this paper
• Junctional adhesion molecule-A: functional diversity through molecular promiscuity

  2017cites this paper
• Développement de formulations polymériques de S-nitrosoglutathion comme traitement per os pour prévenir les maladies inflammatoires chroniques de l’intestin

  2017cites this paper
• Platelet JAM-A in vascular Inflammation and remodeling

  2015cites this paper
• Epithelial adhesion molecules and the regulation of intestinal homeostasis during neutrophil transepithelial migration

  2015cites this paper
• Infectionfor Feline Calicivirus Binding and Feline Junctional Adhesion Molecule Identification of Regions and Residues in

  2014cites this paper
• Development of new antiatherosclerotic and antithrombotic drugs utilizing F11 receptor (F11R/JAM‐A) peptides

  2014cites this paper
• Trans-dimerization of JAM-A regulates Rap2 and is mediated by a domain that is distinct from the cis-dimerization interface

  2014cites this paper
• Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling

  2013cites this paper
• A novel role for junctional adhesion molecule‐A in tumor proliferation: Modulation by an anti‐JAM‐A monoclonal antibody

  2013cites this paper
• JAM-A protects from thrombosis by suppressing integrin αIIbβ3-dependent outside-in signaling in platelets.

  2012cites this paper
• Clinical reviews in allergy and immunology

  2012cites this paper
• Die Expression von Junctional Adhesion Molecule-A auf humanen CD34 + Zellen fördert deren Adhäsion und Differenzierung zu endothelialen Progenitorzellen

  2011cites this paper
• Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines

  2011influential citation
• Junctional Adhesion Molecules (JAMs) - New Players in Breast Cancer?

  2011cites this paper
• JAM-A is a novel surface marker for NG2-Glia in the adult mouse brain

  2010cites this paper
• Regulation of prostate-specific antigen expression by the junctional adhesion molecule A.

  2009cites this paper
• Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration.

  2009cites this paper
• Mechanisms of Outside‐in Signaling at the Tight Junction by Junctional Adhesion Molecule A

  2009cites this paper
• Intestinal barrier function: molecular regulation and disease pathogenesis.

  2009cites this paper
• Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension.

  2009cites this paper
• Studies of Virus Receptor Interactions and Virulence Determinants of Feline Calicivirus

  2008cites this paper
• Regulation of vascular endothelial permeability by junctional adhesion molecules (JAM)

  2007cites this paper
• The F11 receptor (F11R/JAM-A) in atherothrombosis: Overexpression of F11R in atherosclerotic plaques

  2007cites this paper
• Abstracts presented at the Lodz Platelet Conference (held jointly with XIth Erfurt Conference on Platelets), 25--28 June, 2006, Lodz, Poland

  2007cites this paper
• Coronary Artery Disease Association of Plasma Levels of F 11 Receptor / Junctional Adhesion Molecule-A ( F 11 R / JAMA ) With Human Atherosclerosis

  2007cites this paper
• Identification of Regions and Residues in Feline Junctional Adhesion Molecule Required for Feline Calicivirus Binding and Infection

  2007cites this paper
• Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis.

  2007cites this paper
• Junctional adhesion molecule-a participates in the formation of apico-basal polarity through different domains.

  2006cites this paper
• DEVELOPMENTAL EXPRESSION PATTERN OF JUNCTIONAL ADHESION MOLECULE-A (JAM-A)

  2006cites this paper
• Genomic structure, organization and promoter analysis of the human F11R/F11 receptor/junctional adhesion molecule-1/JAM-A.

  2006cites this paper
• The JAM family of proteins.

  2005cites this paper
• Non-lineage antigens: section report.

  2005cites this paper
• Expression of a recombinant protein of the platelet F11 receptor (F11R) (JAM-1/JAM-A) in insect cells: F11R is naturally phosphorylated in the extracellular domain

  2005influential citation
• Junctional Adhesion Molecule 1 Regulates Epithelial Cell Morphology through Effects on β1 Integrins and Rap1 Activity*

  2005cites this paper
• Involvement of the Junctional Adhesion Molecule-1 (JAM1) Homodimer Interface in Regulation of Epithelial Barrier Function*

  2004cites this paper
• Signaling Pathways of the F11 Receptor (F11R; a.k.a. JAM-1, JAM-A) in Human Platelets: F11R Dimerization, Phosphorylation and Complex Formation with the Integrin GPIIIa

  2004cites this paper
• Junctional adhesion molecules (JAMs): more molecules with dual functions?

  2004cites this paper
• The JAM family of junctional adhesion molecules.

  2003cites this paper
• Junctional adhesion molecule 1 (JAM-1).

  2003cites this paper
• F11-Receptor (F11R/JAM) Mediates Platelet Adhesion to Endothelial Cells: Role in Inflammatory Thrombosis

  2002influential citation